Spectrum Analysis in Ex-vivo Human Lungs

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Lung Cancer
Interventions
DEVICE

Spectrum Analysis

The ultrasound probe will be placed on the lung surface in several different directions to obtain the cross section with maximum diameter. Three spectral parameters including midband-fit (dB), intercept (dB), and slope (dB/MHz) will be calculated and compared between the tumor and the lung.

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03356743 - Spectrum Analysis in Ex-vivo Human Lungs | Biotech Hunter | Biotech Hunter